Azalea Health Version 2.1 ONC Drummond Certified – 2014 Edition Complete Information

Azalea Health’s Azalea EHR version 2.1 was 2014 Stage 2 certified under Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program on 10/08/2015.

Drummond Group’s ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology.

Because the Azalea solution is cloud-based and compliant, our customers don’t have to worry about upgrading to a new version.

Unique certification number:

CHPL ID: 10082015-3440-5

Criteria to which Azalea EHR is certified:

170.314(a)(1)  COMPUTERIZED PROVIDER ORDER ENTRY

170.314(a)(3)  DEMOGRAPHICS

170.314(a)(5)  PROBLEM LIST

170.314(a)(6)  MEDICATION LIST

170.314(a)(7)  MEDICATION ALLERGY LIST

170.314(a)(8)  CLINICAL DECISION SUPPORT

170.314(b)(1)  TRANSITIONS OF CARE – RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES

170.314(b)(2)  TRANSITIONS OF CARE – CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES

170.314(b)(7)  DATA PORTABILITY

170.314(c)(1)  CLINICAL QUALITY MEASURES – CAPTURE AND EXPORT

170.314(c)(2)  CLINICAL QUALITY MEASURES – IMPORT AND CALCULATE

170.314(c)(3)  CLINICAL QUALITY MEASURES – ELECTRONIC SUBMISSION

170.314(d)(1)  AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION

170.314(d)(2)  AUDITABLE EVENTS AND TAMPER-RESISTANCE

170.314(d)(3)  AUDIT REPORT(S)

170.314(d)(4)  AMENDMENTS

170.314(d)(5)  AUTOMATIC LOG-OFF

170.314(d)(6)  EMERGENCY ACCESS

170.314(d)(7)  END-USER DEVICE ENCRYPTION

170.314(d)(8)  INTEGRITY

170.314(g)(4)  QUALITY MANAGEMENT SYSTEM

Clinical Quality Measures to which Azalea EHR is certified:

CMS2  PREVENTIVE CARE AND SCREENING: SCREENING FOR CLINICAL DEPRESSION AND FOLLOW-UP PLAN

CMS22  PREVENTIVE CARE AND SCREENING: SCREENING FOR HIGH BLOOD PRESSURE AND FOLLOW-UP DOCUMENTED

CMS50  CLOSING THE REFERRAL LOOP: RECEIPT OF SPECIALIST REPORT

CMS52  HIV/AIDS: PNEUMOCYSTIS JIROVECI PNEUMONIA (PCP) PROPHYLAXIS

CMS56  FUNCTIONAL STATUS ASSESSMENT FOR HIP REPLACEMENT

CMS61  PREVENTIVE CARE AND SCREENING: CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C) TEST PERFORMED

CMS62  HIV/AIDS: MEDICAL VISIT

CMS64  PREVENTIVE CARE AND SCREENING: RISK- STRATIFIED CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C)

CMS65  HYPERTENSION: IMPROVEMENT IN BLOOD PRESSURE

CMS66  FUNCTIONAL STATUS ASSESSMENT FOR KNEE REPLACEMENT

CMS68  DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD

CMS69  PREVENTIVE CARE AND SCREENING: BODY MASS INDEX (BMI) SCREENING AND FOLLOW-UP

CMS74  PRIMARY CARIES PREVENTION INTERVENTION AS OFFERED BY PRIMARY CARE PROVIDERS, INCLUDING DENTISTS

CMS75  CHILDREN WHO HAVE DENTAL DECAY OR CAVITIES

CMS77  HIV/AIDS: RNA CONTROL FOR PATIENTS WITH HIV

CMS82  MATERNAL DEPRESSION SCREENING

CMS90  FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS

CMS117  CHILDHOOD IMMUNIZATION STATUS

CMS122  DIABETES: HEMOGLOBIN A1C POOR CONTROL

CMS123  DIABETES: FOOT EXAM

CMS124  CERVICAL CANCER SCREENING

CMS125  BREAST CANCER SCREENING

CMS126  USE OF APPROPRIATE MEDICATIONS FOR ASTHMA

 CMS127 Met

CMS127  PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS

CMS128  ANTI-DEPRESSANT MEDICATION MANAGEMENT

CMS129  PROSTATE CANCER: AVOIDANCE OF OVERUSE OF BONE SCAN FOR STAGING LOW RISK PROSTATE CANCER PATIENTS

CMS130  COLORECTAL CANCER SCREENING

CMS131  DIABETES: EYE EXAM

CMS132  CATARACTS: COMPLICATIONS WITHIN 30 DAYS FOLLOWING CATARACT SURGERY REQUIRING ADDITIONAL SURGICAL PROCEDURES

CMS133  CATARACTS: 20/40 OR BETTER VISUAL ACUITY WITHIN 90 DAYS FOLLOWING CATARACT SURGERY

CMS134  DIABETES: URINE PROTEIN SCREENING

CMS135  HEART FAILURE (HF): ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)

CMS136  ADHD: FOLLOW-UP CARE FOR CHILDREN PRESCRIBED ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) MEDICATION

CMS137  INITIATION AND ENGAGEMENT OF ALCOHOL AND OTHER DRUG DEPENDENCE TREATMENT

CMS138  PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION

CMS139  SCREENING FOR FUTURE FALL RISK

CMS140  BREAST CANCER: HORMONAL THERAPY FOR STAGE IC-IIIC ESTROGEN RECEPTOR/PROGESTERONE RECEPTOR (ER/PR) POSITIVE BREAST CANCER

CMS141  COLON CANCER: CHEMOTHERAPY FOR AJCC STAGE III COLON CANCER PATIENTS

CMS142  DIABETIC RETINOPATHY: COMMUNICATION WITH THE PHYSICIAN MANAGING ONGOING DIABETES CARE

CMS143  PRIMARY OPEN ANGLE GLAUCOMA (POAG): OPTIC NERVE EVALUATION

CMS144  HEART FAILURE (HF): BETA-BLOCKER THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)

CMS145  CORONARY ARTERY DISEASE (CAD): BETA-BLOCKER THERAPY- PRIOR MYOCARDIAL INFARCTION (MI) OR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVEF <40%)

CMS146  APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS

CMS147  PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION

CMS148  HEMOGLOBIN A1C TEST FOR PEDIATRIC PATIENTS

CMS149  DEMENTIA: COGNITIVE ASSESSMENT

CMS153  CHLAMYDIA SCREENING FOR WOMEN

CMS154  APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER RESPIRATORY INFECTION (URI)

CMS155  WEIGHT ASSESSMENT AND COUNSELING FOR NUTRITION AND PHYSICAL ACTIVITY FOR CHILDREN AND ADOLESCENTS

CMS156  USE OF HIGH-RISK MEDICATIONS IN THE ELDERLY

CMS157  ONCOLOGY: MEDICAL AND RADIATION – PAIN INTENSITY QUANTIFIED

CMS158  PREGNANT WOMEN THAT HAD HBSAG TESTING

CMS159  DEPRESSION REMISSION AT TWELVE MONTHS

CMS160  DEPRESSION UTILIZATION OF THE PHQ-9 TOOL

CMS161  MAJOR DEPRESSIVE DISORDER (MDD): SUICIDE RISK ASSESSMENT

CMS163  DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT

 CMS164 Met

CMS164  ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC

CMS165  CONTROLLING HIGH BLOOD PRESSURE

CMS166  USE OF IMAGING STUDIES FOR LOW BACK PAIN

CMS167  DIABETIC RETINOPATHY: DOCUMENTATION OF PRESENCE OR ABSENCE OF MACULAR EDEMA AND LEVEL OF SEVERITY OF RETINOPATHY

CMS169  BIPOLAR DISORDER AND MAJOR DEPRESSION: APPRAISAL FOR ALCOHOL OR CHEMICAL SUBSTANCE USE

CMS177  CHILD AND ADOLESCENT MAJOR DEPRESSIVE DISORDER: SUICIDE RISK ASSESSMENT

CMS179  ADE PREVENTION AND MONITORING: WARFARIN TIME IN THERAPEUTIC RANGE.

CMS182  ISCHEMIC VASCULAR DISEASE (IVD): COMPLETE LIPID PANEL AND LDL CONTROL

CQM Domains to with Azalea EHR has been certified:

Care Coordination

Efficient Use of Healthcare Resources  

Patient Safety

Clinical Process/Effectiveness  

Population/Public Health  

Patient & Family Engagement  


Additional software use demonstrate compliance with certification criteria:

Dr. First
Phimail

ONC Disclaimer:

This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.  


Cost and Limitations: